cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs AXOlabs

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axcelead/axolabs

CategoryAxcelead Drug Discovery Partners, Inc.AXOlabs
Listed sitecroboth
SummaryAxcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Biomarker Assays
  • Flow Cytometry Services
  • Bioanalysis
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Proteomics Services
  • Pathology & Histology Services
  • Translational Research
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Bioinformatics & Data Science
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro Pharmacology
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Peptide
  • Oligonucleotide
Indications
  • Oncology
  • Immunology
  • Neurology
  • Nephrology
  • Metabolic
  • Cardiovascular
Data not yet provided.
LocationsData not yet provided.
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
CertificationsData not yet provided.
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.